Last reviewed · How we verify
MMS Plus
MMS Plus is a micronutrient supplementation formulation designed to address multiple micronutrient deficiencies simultaneously.
MMS Plus is a micronutrient supplementation formulation designed to address multiple micronutrient deficiencies simultaneously. Used for Micronutrient deficiency in maternal and child health populations.
At a glance
| Generic name | MMS Plus |
|---|---|
| Sponsor | Aga Khan University |
| Drug class | Micronutrient supplement |
| Modality | Small molecule |
| Therapeutic area | Nutrition / Public Health |
| Phase | Phase 3 |
Mechanism of action
MMS Plus appears to be a multi-micronutrient supplement combining essential vitamins and minerals to improve nutritional status and health outcomes. The formulation targets populations at risk of micronutrient malnutrition, particularly in resource-limited settings. It is being evaluated in Phase 3 trials, likely for maternal and child health or general nutritional supplementation.
Approved indications
- Micronutrient deficiency in maternal and child health populations
Common side effects
- Gastrointestinal upset
- Nausea
Key clinical trials
- Inforatio Technique to Promote Wound Healing of Diabetic Foot Ulcers (NA)
- Multiple Micronutrient Supplementation With Digital Layering Among Adolescents in Tanzania (NA)
- BCC-One-Stop-Study (NA)
- Effectiveness and Safety of X A-DERM™ Microsurfaced Acellular Dermal Matrix for Wound Healing After MOHS Surgery (NA)
- Iron Absorption From IFA and MMS Supplements in Kenyan Women During the Second Trimester of Pregnancy (NA)
- Assessing Health System Readiness for Scaling Antenatal MMS in Cambodia
- Implementation of a Personalised Health Plan (PHP) on Patient Quality of Life Score at 2-year Follow-up (NA)
- Physical Activity, Life Satisfaction and Medication Adherence in Older Adults
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- MMS Plus CI brief — competitive landscape report
- MMS Plus updates RSS · CI watch RSS
- Aga Khan University portfolio CI